1. The relationship between bronchoalveolar lavage fluid cytology and airway hyper‐reactivity in a population of Australian horses presented for poor performance. Issue 9 (8th July 2019) Authors: Secombe, CJ; van Eps, AW; Bruce, M; Lester, GD Journal: Australian veterinary journal Issue: Volume 97:Issue 9(2019) Page Start: 343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PMO-178 The significance of viral and serological markers in predicting liver disease severity in e-Ag negative hepatitis b virus infection. (28th May 2012) Authors: Audimoolam, V K; Carey, I; Bruce, M; Horner, M; Abid, S; Agarwal, K; Harrison, P Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Sporadic Creutzfeldt–Jakob disease in two adolescents. Issue 1 (23rd May 2007) Authors: Murray, K; Ritchie, D L; Bruce, M; Young, C A; Doran, M; Ironside, J W; Will, R G Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 79:Issue 1(2008) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P57 The IL28B gene SNP rs12979860 CC haplotype, predictor of response to treatment in chronic HCV infection, is associated to high numbers of CD56bright NK cells, low numbers of CD3-CD56-CD16+ NK cells and low HCV-specific IL-10 production. (6th September 2011) Authors: Carey, I; Bruce, M; Mendes, A; Scalori, A; Joshi, D; Agarwal, K; Mieli-Vergani, G; Vergani, D Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P47 De-novo antiviral therapy with nucleos(t)ide analogues in 'real-life' patients with chronic hepatitis B infection: comparison of virological responses between lamivudine + adefovir vs entecavir vs tenofovir therapy. (6th September 2011) Authors: Carey, I; Nguyen DorothyJoe, H; Al-Freah, M; Knighton, S; Bruce, M; Suddle, A; Harrison, P M; Agarwal, K Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P60 Pre-treatment IP-10 concentrations are associated with a sustained virological response in HIV/HCV co-infected patients. (6th September 2011) Authors: Joshi, D; Bruce, M; Suddle, A; Taylor, C; Carey, I; Agarwal, K Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P58 Genetic, virological and immunological pre-treatment predictors of therapy response to Peg-IFN/ribavirin in children with chronic hepatitis C. (6th September 2011) Authors: Carey, I; Bruce, M; Bansal, S; Tizzard, S; Joshi, D; Vergani, D; Mieli-Vergani, G Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P77 A Pharmacist delivered stratified conversion protocol from Hepatitis B Immunoglobulin (HBIG) to tenofovir or entecavir is efficacious, safe and cost-effective for prevention of recurrence of Hepatitis B virus (HBV) in Liver Transplant (LT) recipients. (6th September 2011) Authors: Knighton, S; Agarwal, K; Heneghan, M; O'Grady, J; Bruce, M; Carey, I; Heaton, N; Suddle, A Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P95 Molecular mechanisms of monocyte reprogramming in acute liver failure: importance of hepatically derived anti-inflammatory mediators. (6th September 2011) Authors: Antoniades, C G; Zingarelli, V; Possamai, L; Mistry, R; Abeles, R D; Bruce, M; McPhail, M J W; Heaton, N; Auzinger, G; Bernal, W; Vergani, D; Thursz, M R; Wendon, J A Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P67 Switch to other nucleos(t)ide analogues therapy in chronic hepatitis B cohort on long-term de-novo combination therapy with lamivudine plus adefovir: efficacy and safety. (6th September 2011) Authors: Carey, I; Mendes, A; Joshi, D; Bruce, M; Knighton, S; Scalori, A; Hughes, S; Al-Freah, M; Suddle, A; Harrison, P M; Agarwal, K Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗